Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.
Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback